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Background. The Free Radical Theory of Aging mechanistically links oxidative stress to aging. Okinawa has among the world’s
longest-lived populations but oxidative stress in this population has not been well characterized. Methods.W ec o m p a r e dp l a s m a
lipid peroxide (LPO) and vitamin E—plasma and intracellular tocopherol levels (total α, β,a n dγ), in centenarians with
younger controls. Results. Both LPO and vitamin E tocopherols were lower in centenarians, with the exception of intracellular β-
tocopherol, which was signiﬁcantly higher in centenarians versus younger controls. There were no signiﬁcant diﬀerences between
age groups for tocopherol: cholesterol and tocopherol: LPO ratios. Correlations were found between α-Tocopherol and LPO in
septuagenarians but not in centenarians. Conclusions. The low plasma level of LPO in Okinawan centenarians, compared to
youngercontrols,argues forprotection againstoxidativestress inthe centenarianpopulation andis consistentwith thepredictions
oftheFree RadicalTheoryofAging.However,thepresentworkdoesnotstronglysupportaroleforvitaminEinthisphenomenon.
The role of intracellular β-tocopherol deserves additional study. More research is needed on the contribution of oxidative stress
and antioxidants to human longevity.
1.Introduction
Human longevity is a complex phenotype that is determined
byenvironment,genetics,and chance[1].Understandingthe
mechanisms by which aging leads to longevity, particularly
healthy longevity would be of enormous beneﬁt to our aging
population. Unfortunately, most research on human aging
has focused on phenomenological description of age-related
diseases, and much less is known about the mechanisms of
aging itself [2]. Among the most promising theories about
how and why we age is the Free Radical Theory, initially
proposed by Denham Harman in 1956 [3].
Harman proposed that oxygen radicals produced during
aerobic respiration induce oxidative damage in DNA, cells,
tissues, and organisms that lead to aging and death. Studies
in Harman [3] hypothesized, based on observations of enzy-
matic redoxchemistry, that oxygenradical generationoccurs
in vivo and that mechanisms exist to protect against such
damage. Mitochondria were later found to be a principal
source of these oxygen radicals [4]. The enzyme superoxide
dismutase (SOD) provided early evidence for endogenous
antioxidant defenses against such radical damage [5]. Exoge-
nousantioxidantdefendershavealsobeendiscoveredinfood
sources, among the most studied being vitamin E [6, 7].2 Current Gerontology and Geriatrics Research
Vitamin E consists of a group of eight related fat soluble
tocopherols and tocotrienols, which have signiﬁcant antiox-
idant properties [6]. The highest bioavailability, absorption,
and metabolization occur with α-tocopherol [7].
Some research supports α-tocopherol as the most impor-
tant lipid soluble antioxidant since it protects cell mem-
branes from chain reactions caused by radical-induced lipid
peroxidation through quenching free radical intermediates
[7]. While the antioxidant role of other forms of vitamin E
is less clear, γ-tocopherol is a nucleophile that can quench
electrophilic mutagens, β-tocopherol has similar properties,
and tocotrienols can protect neurons from oxidative stress
[8–10].
Based on this background, we and others have inves-
tigated LPO, SOD, and vitamin E as potential factors in
human aging and longevity. Plasma LPO has been found
to increase with age into the septuagenarian years [11]b u t
little is known about population levels in exceptionally aged
individuals, such as centenarians. Studies in Mezzetti et al.
[12] found that lower plasma lipid peroxide and higher
plasma vitamin E predicted lower risk of cardiovascular
events (an important cause of premature mortality) in
healthy Italian octogenarians over a 4-year period. Studies
in Suzuki et al. [13] found that plasma LPO was lower
in Okinawan centenarians than septuagenarians, consistent
with their demographic selection against mortality. This
is consistent with the hypothesis that protection against
oxidativestress mightbeasurvival factorinolderOkinawans
and possibly a marker of “slower” aging.
In order to assess potential connections between LPO
andcommonendogenousorexogenousantioxidants,Suzuki
et al. [14] studied whether Okinawan centenarians also dis-
played high levels of plasma or intracellular SOD. Contrary
to expectations, SOD levels were lower in centenarians than
in younger controls. This might be, in part, a reaction to low
levels of oxidative stress in centenarians but it does not oﬀer
support for SOD as a major protector against oxidativestress
in this population.
Conversely, vitamin E intake is known to be high in the
traditional Okinawan diet due to abundant consumption
of foods such as soy beans (tofu and soy bean oils), sweet
potatoes, papaya (and its leaves), and green leafy vegetables
(e.g., swiss chard, spinach, mustard greens, and numerous
other local varieties) [15, 16]. This is reﬂected in relatively
high plasma α-tocopherol in older Okinawans, who are
more likely to consume a traditional diet [13]. A recent
comparative study found that mean α-tocopherol levels were
similar between Okinawan elderly and healthy elderly from
the USA (Oregon) with and without adjustments for total
cholesterol or triglycerides [16]. This was despite the fact
that few Okinawans consumed vitamin supplements while
more than a third of US elders did. α-tocopherol is typically
the most abundant tocopherol in human serum since it is
preferentially conserved by the liver. For example, one study
of middle-aged Japanese women found that α-tocopherol
formed 88% of serum tocopherol, while the reminder
consisted of 8.5% γ-tocopherol, 1.8% δ-tocopherol, and
1.7% β-tocopherol [17].
Foods also vary markedly in their tocopherol content.
For example, soy oil is mainly γ-tocopherol (>60%) whereas
sunﬂower oil is mainly α-tocopherol(>90%)[17]. Fewfoods
have a signiﬁcant quantity of β-tocopherol [18]b u ts o m e
traditional Okinawan foods, including brown seaweed and
hot red peppers, are rich in β-tocopherol; soy oil (in tofu,
other soy foods and cooking oil), while not as β-tocopherol-
rich, is consumed in quite high quantity, particularly in
the traditional Okinawan diet, which is more likely to be
consumed by centenarians [19].
Asanimportantfatsolubleantioxidant,VitaminEand/or
its various tocopherols could theoretically explain the low
L P Oi nO k i n a w a nc e n t e n a r i a n s .H o w e v e r ,S u z u k ie ta l .[ 13,
14, 20] showed in prior work that vitamin E, like SOD,
was signiﬁcantly lower in the plasma of centenarians than
of younger controls, even after adjustment for lipids and
other factors. Nevertheless, vitamin E subtypes (tocopherol
subtypes) and/or intracellular tocopherol levels were not
studied. Since the major exposure to oxidative stress in
humans originates from mitochondria and this stress occurs
mainly intracellularly, it is possible that intracellular con-
centrations of vitamin E (or its subtypes) may be more
important than plasma vitamin E.
Therefore,westudiedOkinawancentenariansandyoung-
er control populations with the following primary aims: (1)
to quantify blood levels of lipid peroxide (LPO), a common
proxy measure of oxidative stress; (2) to quantify blood and
intracellularlevelsofvitaminE(measuredinredbloodcells),
a common antioxidant; (3) to assess potential correlations
between LPO and vitamin E levels.
2.Materialsand Methods
This study was conducted under ongoing Institutional Re-
view Board approval from Okinawa International University,
a n di n f o r m e dc o n s e n tw a sr e c e i v e df r o ma l ls t u d yp a r t i c i -
pants. A total of 139 centenarians (30 males, 109 females,
mean age = 100.3 years), residing in Okinawa, were previ-
ouslystudiedandhadbankedbloodsamples[20].Additional
younger controls were recruited for comparison purposes in
the current study. A physical examination was performed at
the participants’ place of residence. Examination included
hematological and biochemical analysis of blood, activity of
daily living survey, and anthropometric measurements. For
the control group, 79 healthy community-dwelling people
(34 males, 45 females, aged 20–80, mean age 62.5 years)
were recruitedandsubjectedtoidenticalexaminations under
similar conditions. These controls consisted of younger
(twenties, thirties) and older (sixties, seventies, eighties)
participants. Total numbers of cases and controls varied
according to the particular assay performed.
Blood samples were taken in EDTA tubes and stored
on ice. Samples were then transported to the University
of the Ryukyus Hospital, where they were separated into
plasma and blood cell components by centrifugation. Ultra-
centrifugation was used to evaluate plasma total cholesterol
and cholesterol subfractions. LPO was measured using the
thiobarbituric acid (TBA) reaction for fatty acid oxidationCurrent Gerontology and Geriatrics Research 3
otherwise known as the “TBA method” [21, 22]. For toco-
pherol studies, samples were frozen on dry ice and sent to
Eizai Research Institute, where tocopherol concentrations
were measured by high performance liquid chromatography
(HPLC) [23]. Cases and controls were compared using
Student’st-test.
3.Results
Table 1 demonstrates that plasma LPO levels of centenarians
were 1.49 ± 0.51nmol/ml in males (n = 30), 1.72 ±
1.28nmol/mlforfemales(n = 109),and1.67±1.16nmol/ml
overall (n = 139). Centenarians had signiﬁcantly lower LPO
levels than control subjects in their twenties (n = 8; 3.30 ±
1.25; P<. 001), thirties (n = 16; 3.51 ± 1.08; P<. 001),
seventies (n = 29; 3.40±0.79;P<. 001),and eighties (n = 8;
2.91 ± 0.34; P<. 001).
Table 2 displays average (mean) plasma tocopherol levels
(total and by subtype) across age strata. Total plasma
tocopherol (T-Toc) in centenarians was 8.89 ± 2.31μg/ml
for males (n = 19) and 11.05 ± 3.41μg/ml for females
(n = 91), and 10.58 ± 3.32 for both groups combined
(n = 110). Centenarian plasma T-tocopherol (males and
females combined) was signiﬁcantly lower than that of every
younger age group (P<. 001). This trend generally held true
for both genders as well, with T-tocopherol increasing with
age in both genders until the age of 70s and then dropping
thereafter.
We also compared the levels of plasma tocopherol
subtypes (α-, β-, γ-tocopherol) in centenarians to younger
controls. Plasma α-tocopherol in centenarian males (7.79 ±
2.10μg/ml, n = 19), females (9.82 ± 3.35, n = 72),
a n dc o m b i n e dt o t a l( 9 .37 ± 3.32μg/ml, n = 91) showed
similar trends as T-Toc, with combined plasma α-tocopherol
level in centenarians signiﬁcantly lower than in younger age
groups across all age strata (signiﬁcance levels ranged from
P<. 05 to P<. 001). Comparisons of centenarians across
age strata within gender groups were signiﬁcant between
septuagenarians in females and between all age groups in
males. This was partly limited by small numbers. For both
genders α-tocopherol tended to increase with age and peak
at septuagenarian years, then dropped rapidly thereafter.
Total plasma β-tocopherol levels in centenarian males
(0.18 ± 0.07μg/ml, n = 18), females (0.20 ± 0.21μg/ml, n =
69), and gender combined total (0.20 ± 0.19μg/ml, n = 87)
were signiﬁcantly lower than in septuagenarians but not in
other age groups (male P<. 05; female P<. 01). Similar
relations were seen as with α-tocopherol where peak values
appeared in the septuagenarian years and dropped rapidly
thereafter.
Plasma γ-tocopherol levels for centenarian males (0.93±
0.42μg/ml, n = 18), centenarian females (1.03 ± 0.59μg/ml,
n = 72), and both genders combined (1.01±0.52μg/ml, n =
90)weresigniﬁcantly lowerthan septuagenarians withregard
to the combined (P<. 05) and female (P<. 05) centenarian
groups. Levels tended to peak in the septuagenarian years
for the combined group and were less reliable in individual
groups, possibly due to small numbers.
Gender-related diﬀerences appeared with signiﬁcantly
higher T-tocopherol (P<. 05) and α-tocopherol (P<. 01)
found in female centenarians compared to male centenari-
ans.
Table 3 demonstrates comparisons between intracellular
tocopherol levels (total and by subtype) between cente-
narians and controls in various age strata. Intracellular T-
tocopherol in centenarian red blood cells in males (1.80 ±
1.00μg/ml, n = 19), females (2.30 ± 1.22μg/ml, n = 77),
and both sexes combined (2.19 ± 1.19μg/ml, n = 96) was
signiﬁcantly lower than in all other age groups for combined
genders versus all individual age strata (P<. 001). This
relation held when separated by gender for most individual
age groups.
Intracellular concentration of individual tocopherol sub-
types (α-Toco, β-Toco, γ-Toco) was also compared between
age groups by gender. In centenarians, α-tocopherol levels in
males (1.51±0.84μg/ml,n = 19),females(2.00±1.13μg/ml,
n = 77),andbothsexescombined(1.89±1.09μg/ml,n = 96)
were signiﬁcantly lower than in all younger age groups when
both sexes combined were compared to younger age groups;
signiﬁcance levels ranged from P<. 05 (octogenarians)
to P<. 001 (septuagenarians). Peak values tended to be
reached in octogenarian years in females with no clear
patternin males until a sharp declinein centenarians of both
genders.
Intracellular concentration of β-Toco in male cente-
narians (0.08 ± 0.04μg/ml, n = 10), female centenarians
(0.10 ± 0.08μg/ml, n = 37), and both sexes combined
(0.09 ± 0.07μg/ml, n = 47) was the highest of all age
groups. However, only the diﬀerence between centenarians
and controls in their seventieswas signiﬁcant (P<. 05 males;
P<. 01 females; P<. 01 combined). This was likely due
to the small numbers of study participants in individual
age groups other than the septuagenarian age group, since
concentrationsdidnotappeartobediﬀerentacrossagestrata
until centenarian years.
Intracellular concentration of γ-tocopherol in centenar-
ian males (0.25 ± 0.16μg/ml, n = 18), females (0.23 ±
0.19μg/ml, n = 74), and both sexes combined (0.24 ±
0.18μg/ml;n = 92)appearedlowerthanall otheragegroups.
However, it reached signiﬁcance versus only two groups—
septuagenarian females (P<. 05) and septuagenarian sexes
combined (P<. 05). Lack of signiﬁcant diﬀerence between
centenarians and other groups may have been inﬂuenced by
small numbers of participants in comparison groups.
Table 4 demonstrates T-tocopherol, α-tocopherol, and γ-
tocopherol in centenarians versus a younger control group
(septuagenarians) separated by gender and adjusted for
plasma total cholesterol (Tc) and HDL cholesterol (HDL-
C) by dividing tocopherol levels by cholesterol levels. This
comparison was important since diﬀerences in tocopherol
b e t w e e na g eg r o u p sm i g h tb ea na r t i f a c to fd i ﬀerences in
plasma lipid levels that occur commonly with age. Older
populations (age 70 years or more) tend to have lower
cholesterollevels,which maypartlyreﬂect malnutrition[24].
As a fat soluble vitamin, most tocopherol is carried in lipid
subfractions andthereforemight appearartiﬁcially lowifnot
adjusted by plasma lipid levels. Despite adjustment, there4 Current Gerontology and Geriatrics Research
Table 1: Plasma lipid peroxide in young, middle-aged, and older age groups (mean and SD), nmol/ml. LPO levels were measured using the
TBA method [21, 22].
20s 30s 70s 80s 100s
Male
(n)
3.34±1.79
(4)
4.06±1.24
(8)∗∗∗
3.15±0.70
(11)∗∗∗
2.92±0.32
(5)∗∗∗
1.49±0.51
(30)
Female
(n)
3.18±0.64
(4)∗
2.95±0.53
(8)∗∗
3.56±0.81
(18)∗∗∗
2.90±0.46
(3)
1.72±1.28
(109)
Total
(n)
3.30±1.25
(8)∗∗∗
3.51±1.08
(16)∗∗∗
3.40±0.79
(29)∗∗∗
2.91±0.34
(8)∗∗∗
1.67±1.16
(139)
Signiﬁcant diﬀerence between centenarians and particular age group: ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001.
Table 2: Mean plasma tocopherol (total and subtype) by age group (μg/ml).
Age 20s 30s 70s 80s 100s
α Toc
Male
(n)
11.81 ±3.03
(4)∗∗
12.35 ±3.60
(8)∗∗
13.15± 7.82
(17)∗
9.44 ±1.07
(5)∗
7.79 ±2.10
(19)
Female
(n)
9.58 ±2.62
(4)
11.07 ±3.91
(8)
16.31±11.64
(30)∗∗
13.58 ±3.63
(3)
9.82 ±3.35
(72)
Total
(n)
10.69 ±2.88
(8)∗∗
11.71 ±3.69
(16)∗∗
15.14±11.41
(47)∗∗∗
11.28 ±3.20
(8)∗
9.37 ±3.32
(91)
β Toc
Male
(n)
0.25 ±0.04
(4)
0.22 ±0.05
(8)
0.23 ±0.08
(17)∗
0.20 ± 0.05
(5)
0.18 ±0.07
(18)
Female
(n)
0.22 ±0.04
(4)
0.21 ±0.04
(8)
0.31 ±0.18
(30)∗∗
0.28 ± 0.13
(3)
0.20 ±0.21
(69)
Total
(n)
0.23 ±0.04
(8)
0.21 ±0.04
(16)
0.28 ±0.16
(47)∗∗
0.23 ± 0.09
(8)
0.20 ±0.19
(87)
γ Toc
Male
(n)
1.37 ±0.58
(4)
1.17 ±0.40
(8)
1.00 ±0.51
(17)
1.18 ± 0.33
(5)
0.93 ±0.42
(18)
Female
(n)
0.98 ±0.22
(4)
1.04 ±0.50
(8)
1.62 ±1.76
(30)∗
1.16 ± 0.17
(3)
1.03 ±0.59
(72)
Total
(n)
1.17 ±0.46
(8)
1.11 ±0.44
(16)
1.39 ±1.45
(47)∗
1.17 ± 0.49
(8)
1.01 ±0.52
(90)
Total Toc
Male
(n)
13.42 ±3.60
(4)∗∗
13.74 ±3.70
(8)∗∗∗
14.38± 8.28
(17)∗
10.82 ± 1.37
(5)∗
8.89 ±2.31
(19)
Female
(n)
10.78 ±2.80
(4)∗∗∗
12.33 ±3.87
(8)
18.24±12.69
(30)∗∗∗
15.01 ± 3.62
(3)∗∗∗
11.05 ±3.41
(91)
Total
(n)
12.10 ±3.31
(8)∗∗∗
13.03 ±3.73
(16)∗∗∗
16.81±11.32
(47)∗∗∗
12.68 ± 3.27
(8)∗∗∗
10.58 ±3.32
(110)
Toc: Tocopherol.
Signiﬁcant diﬀerence between centenarians and particular age group: ∗P<. 05; ∗∗P<0.01; ∗∗∗P<. 001.
Signiﬁcant diﬀerence between male and femalecentenarians: P<. 01 in α Toc; P<. 05 in total Toc.
were no signiﬁcant diﬀerences between centenarians and
septuagenarians across age strata.
Tables 5 and 6 show tocopherol: LPO ratios in plasma
(Table 5) and intracellular (Table 6) compartments across
age strata, separated by gender. No signiﬁcant diﬀerences
were found for either gender between the centenarians and
controls in their seventies.
Table 7 shows correlation indices between plasma toco-
pherol/tocopherol subfractions and LPO as well as between
intracellular tocopherol and LPO in two age groups: cente-
narians and septuagenarians. In centenarians, no signiﬁcant
correlations were found between plasma tocopherol nor
tocopherol subfractions and LPO. However, in septuage-
narians there were some correlations between tocopherol
levels and LPO: (1) a weakly positive correlation was found
between plasma T-tocopherol and LPO (r = .34; P<. 01),
and between α-tocopherol and LPO (r = .33; P<. 01);
(2) a weakly negative correlation was found between intra-
cellular T-tocopherol and LPO (r =− .32; P<. 05) and
between intracellular α-tocopherol and LPO (r =− .29; P<
.05).
4.Discussion
In 1956 Harman proposed the Free Radical Theory of aging
[3]. He hypothesized that aging is partly due to cumulative
oxidative damage, and over the last four decades many
studies have supported this view. For example, the literature
shows that a progressive accumulation of oxidation-derived
damage to cellular machinery is linked to senescence [2, 25].Current Gerontology and Geriatrics Research 5
Table 3: Mean intracellular (red blood cell) tocopherol levels by age strata (total and subtype) (μg/ml).
20s 30s 70s 80s 100s
α Toc
Male
(n)
2.47 ±0.49
(4)∗∗
2.43 ±0.35
(8)∗∗
2.48 ± 0.25
(17)∗∗∗
2.46 ±0.28
(5)∗
1.51 ±0.84
(19)
Female
(n)
2.53 ±0.35
(4)
2.79 ±0.82
(8)
2.61 ± 0.76
(30)∗∗∗
2.91 ±0.87
(3)
2.00 ±1.13
(77)
Total
(n)
2.50 ±0.40
(8)∗∗
2.61 ±0.64
(16)∗∗
2.56 ± 0.62
(47)∗∗∗
2.66 ±0.61
(8)∗
1.89 ±1.09
(96)
β Toc
Male
(n)
0.05 ±0.00
(4)
0.05 ±0.01
(8)
0.04 ± 0.01
(17)∗
0.05 ±0.01
(5)
0.08 ±0.04
(10)
Female
(n)
0.04 ±0.00
(4)
0.04 ±0.01
(8)
0.05 ± 0.02
(30)∗∗
0.06 ±0.02
(3)
0.10 ±0.08
(37)
Total
(n)
0.05 ±0.01
(8)
0.04 ±0.01
(16)
0.05 ± 0.02
(47)∗∗
0.05 ±0.01
(8)
0.09 ±0.07
(47)
γ Toc
Male
(n)
0.35 ±0.06
(4)
0.31 ±0.12
(8)
0.27 ± 0.09
(17)
0.39 ±0.10
(5)
0.25 ±0.16
(18)
Female
(n)
0.35 ±0.08
(4)
0.32 ±0.11
(8)
0.33 ± 0.17
(30)∗
0.31 ±0.16
(3)
0.23 ±0.19
(74)
Total
(n)
0.35 ±0.07
(8)
0.32 ±0.11
(16)
0.31 ± 0.15
(47)∗
0.35 ±0.13
(8)
0.24 ±0.18
(92)
Total Toc
Male
(n)
2.87 ±0.50
(4)∗∗∗
2.76 ±0.41
(8)∗∗∗
2.79 ± 0.30
(17)∗∗∗
2.89 ±0.37
(5)∗
1.80 ±1.00
(19)
Female
(n)
2.92 ±0.39
(4)∗∗∗
3.15 ±0.75
(8)
2.98 ± 0.82
(30)∗∗∗
3.24 ±0.76
(3)∗∗∗
2.30 ±1.22
(77)
Total
(n)
2.90 ±0.42
(8)∗∗∗
2.95 ±0.62
(16)∗∗∗
2.91 ± 0.67
(47)∗∗∗
3.05 ±0.57
(8)∗∗∗
2.19 ±1.19
(96)
Toc: Tocopherol.
Signiﬁcant diﬀerence centenarians and individual age groups: ∗P<. 05; ∗∗P<0.01; ∗∗∗P<. 001.
Lipids, the major component of cell membranes, which
are in close proximity to mitochondria, the key source of
endogenous free radicals, are prime targets for this damage
[26]. As humans age this damage can be observed as a
progressive increase in blood lipid peroxidation byproducts
[26]. Therefore, lipid peroxidation may be a key player for
initiating and/or mediating aspects of the aging process.
Some work suggests that persons who live to exceptional
ages, such as centenarians, might do so by aging more
slowly [27]. If this is the case, then protection against lipid
peroxidation may be a biological advantage that accounts, in
part, for slower aging.
The present work ﬁnds some support for this view.
We conﬁrmed that plasma LPO level increases with age
in Okinawans, a very long-lived population, and drops oﬀ
signiﬁcantly by centenarian years. This is consistent with
as u r v i v o re ﬀect where those with high blood LPO levels
are selected out (by death) leaving a population enriched
with low blood LPO. Some protective endogenous and/or
exogenous antioxidant defenses may be responsible for this
eﬀect. However, there is no clear indication from the present
study that tocopherol and its subtypes (both plasma and
intracellular) are leading biological factors in such a system,
since blood tocopherol was lower in centenarians than in
younger controls, with the possible exception of intracellular
β-tocopherol.
The fact that centenarians had higher intracellular β-
tocopherol is interesting. While plasma β-tocopherol did
not appear protective, some studies suggest that intracellular
concentration of antioxidants might be more relevant
than plasma levels since the source of most free radicals
is intracellular mitochondria, and much damage occurs
intracellularly—to DNA, cell membranes, and other cel-
lular components. In addition, some data suggest that β-
tocopherol might be a more eﬀective antioxidant than α-
tocopherol. For example, β-tocopherol is less likely to act as
a free radical itself after quenching oxygen radicals than α-
tocopherol [9]. This increased stability could, theoretically,
result in better overall protection against oxidative stress.
Researchers in [28]f o u n dt h a ti n c r e a s e dβ-tocopherol was
associated with decreased risk for metabolic syndrome, a
life shortening prediabetic condition that increases oxidative
stress. Researchers in [29] found that replacement of α-
tocopherol by β-tocopherol enhances resistance to oxidative
stress in a cell culture study.
Since tocopherols are lipid soluble, it is also possible
that very old persons, who generally have low blood lipids,
display artiﬁcially low blood tocopherol levels since it is
mainly lipid bound. For example, our past data show
that Okinawan centenarians have signiﬁcantly lower total
cholesterol and cholesterol subfractions (e.g., LDL, HDL)
than elderly controls in their seventies [30]. Therefore, in
older persons, tocopherol: lipid ratios might better reﬂect
physiologic levels than blood tocopherol levels, whether in
plasma orintracellular compartments. Nevertheless,correct-
ing for diﬀerentlipid levelsacross age strata was unrevealing.6 Current Gerontology and Geriatrics Research
Table 4: Plasma and intracellular tocopherols adjusted by lipid subfraction.
Septuagenarians (aged 70s) Centenarians (aged 100s)
Male (n)F e m a l e ( n)T o t a l ( n)M a l e ( n)F e m a l e ( n)T o t a l ( n)
T-Toc/Tc 0.08 ±0.267
(17
￿
0.08 ±0.259
(30
￿
0.08 ±0.283
(47
￿
0.075 ± 0.018
(16
￿
0.072 ±0.023
(68
￿
0.072 ±0.021
(84)
Plasma
α-Toc/Tc 0.07 ±0.252
(17
￿
0.08 ±0.238
(30
￿
0.07 ±0.285
(47
￿
0.06 ± 0.017
(15
￿
0.07 ±0.018
(50
￿
0.07 ±0.017
(65)
Intracellular
T-Toc/Tc 0.016 ±0.010
(17
￿
0.013 ±0.017
(30
￿
0.015 ±0.017
(47
￿
0.015 ± 0.007
(16
￿
0.016 ±0.010
(55
￿
0.016 ±0.009
(71)
α-Toc/Tc 0.014 ±0.008
(17
￿
0.012 ±0.016
(30
￿
0.013 ±0.016
(47
￿
0.013 ± 0.006
(16
￿
0.014 ±0.009
(55
￿
0.013 ±0.009
(71)
γ-Toc/Tc 0.005 ±0.016
(17
￿
0.007 ±0.036
(30
￿
0.007 ±0.036
(47
￿
0.007 ± 0.003
(15
￿
0.007 ±0.004
(50
￿
0.007 ±0.004
(65)
β-Toc/Tc 0.002 ±0.003
(17
￿
0.002 ±0.003
(30
￿
0.002 ±0.004
(47
￿
0.002 ± 0.001
(16
￿
0.002 ±0.002
(54
￿
0.002 ±0.002
(70)
T-Toc/HDL-C 0.27 ±0.55
(17
￿
0.37 ±0.98
(30
￿
0.33 ±0.81
(47
￿
0.28 ± 0.13
(16
￿
0.27 ±0.10
(69
￿
0.27 ±0.11
(85)
Plasma α-Toc/HDL-C 0.25 ±0.52
(17
￿
0.33 ±0.90
(30
￿
0.30 ±0.82
(47
￿
0.25 ± 0.12
(15
￿
0.25 ±0.09
(50
￿
0.25 ±0.09
(65)
γ-Toc/HDL-C 0.019 ±0.03
(17
￿
0.033 ±0.14
(30)
0.027 ±0.10
(47
￿
0.03 ± 0.02
(15
￿
0.03 ±0.02
(50
￿
0.03 ±0.02
(65)
T-Toc/HDL-C 0.052 ±0.020
(17
￿
0.060 ±0.063
(30
￿
0.057 ±0.047
(47
￿
0.059 ± 0.037
(16
￿
0.056 ±0.031
(55
￿
0.058 ±0.032
(71
￿
Intracellular α-Toc/HDL-C 0.047 ±0.017
(17
￿
0.053 ±0.058
(30
￿
0.050 ±0.044
(47
￿
0.049 ± 0.032
(16
￿
0.049 ±0.029
(55
￿
0.049 ±0.030
(71
￿
γ-Toc/HDL-C 0.005 ±0.006
(17
￿
0.007 ±0.013
(30
￿
0.006 ±0.010
(47
￿
0.008 ± 0.006
(16
￿
0.007 ±0.005
(54
￿
0.007 ±0.006
(70
￿
Tc: Total cholesterol; HDL-C: high density lipoprotein cholesterol; Toc: Tocopherol. Note: no signiﬁcant diﬀerences between groups.
Table 5: Average plasma tocopherol fractions/LPO across age strata.
Plasma Toc 20s 30s 70s 80s 100s
Total Toc/LPO
Male
(n)
4.02 ± 2.01
(4
￿
3.38 ±2.98
(8
￿
4.57 ±11.83
(11
￿
3.71 ±4.28
(5
￿
6.43 ±3.61
(16
￿
Female
(n)
3.39 ± 4.38
(4
￿
4.18 ±7.30
(8
￿
5.12 ±15.67
(18
￿
5.18 ±7.87
(3
￿
9.43 ±14.22
(83
￿
Total
(n)
3.67 ± 2.65
(8
￿
3.71 ±3.45
(16
￿
4.94 ±14.33
(29
￿
4.36 ±9.62
(8
￿
8.95 ±13.13
(99
￿
αToc/LPO
Male
(n)
3.54 ± 1.69
(4
￿
3.04 ±2.90
(8
￿
4.17 ±11.17
(11
￿
3.23 ±3.34
(5
￿
5.75 ±3.29
(15
￿
Female
(n)
3.01 ± 4.09
(4
￿
3.75 ±7.38
(8
￿
4.58 ±14.37
(18
￿
4.68 ±7.89
(3
￿
9.07 ±13.86
(67
￿
Total
(n)
3.24 ± 2.30
(8
￿
3.34 ±3.42
(16
￿
4.45 ±13.18
(29
￿
3.88 ±9.41
(8
￿
8.47 ±12.70
(82
￿
βToc/LPO
Male
(n)
0.07 ± 0.02
(4
￿
0.05 ±0.04
(8
￿
0.07 ±0.11
(11
￿
0.07 ±0.16
(5
￿
0.12 ±0.07
(15
￿
Female
(n)
0.07 ± 0.06
(4
￿
0.07 ±0.08
(8
￿
0.09 ±0.22
(18
￿
0.10 ±0.28
(3
￿
0.19 ±0.24
(64
￿
Total
(n)
0.07 ± 0.03
(8
￿
0.06 ±0.04
(16
￿
0.08 ±0.20
(29
￿
0.08 ±0.26
(8
￿
0.17 ±0.26
(79
￿
γToc/LPO
Male
(n)
0.41 ± 0.32
(4
￿
0.29 ±0.32
(8
￿
0.32 ±0.73
(11
￿
0.40 ±1.03
(5
￿
0.63 ±0.47
(15
￿
Female
(n)
0.31 ± 0.34
(4
￿
0.35 ±0.94
8
0.46 ±2.17
(18
￿
0.40 ±1.54
(3
￿
1.06 ±1.59
(67
￿
Total
(n)
0.36 ± 0.37
(8
￿
0.32 ±0.41
(16
￿
0.41 ±1.84
(29
￿
0.40 ±1.44
(8
￿
0.98 ±1.46
(82
￿
Toc: Tocopherol; LPO: lipid peroxidase. Note: no signiﬁcant diﬀerences between groups.Current Gerontology and Geriatrics Research 7
Table 6: Intracellular tocopherol: lipid peroxide ratios across age strata.
Intracellular Toc 20s 30s 70s 80s 100s
Total Toc/LPO
Male
(n)
0.86±0.28
(4)
0.68±0.33
(8)
0.89±0.43
(11)
0.99 ±1.16
(5)
1.21 ± 1.12
(16)
Female
(n)
0.92 ±0.61
(4)
1.07 ±1.42
(8)
0.84±1.00
(18)
1.12 ±1.65
(3)
1.67 ± 1.69
(71)
Total
(n)
0.88 ±0.34
(8)
0.84 ±0.57
(16)
0.86 ± 0.85
(29)
1.05 ±1.68
(8)
1.58 ± 1.60
(87)
α Toc/LPO
Male
(n)
0.74 ±0.27
(4)
0.60 ±0.28
(8)
0.79 ± 0.36
(11)
0.84 ±0.88
(5)
1.02 ± 0.92
(16)
Female
(n)
0.80 ±0.55
(4)
0.95 ±1.55
(8)
0.73 ± 0.94
(18)
1.00 ±1.89
(3)
1.40 ± 1.44
(71)
Total
(n)
0.76 ±0.32
(8)
0.74 ±0.59
(16)
0.75 ± 0.78
(29)
0.91 ±1.79
(8)
1.33 ± 1.36
(87)
β Toc/LPO
Male
(n)
0.01 ±0.00
(4)
0.01 ±0.01
(8)
0.01 ± 0.01
(11)
0.02 ±0.03
(5)
0.06 ± 0.03
(8)
Female
(n)
0.01 ±0.00
(4)
0.01 ±0.02
(8)
0.01 ± 0.02
(18)
0.02 ±0.04
(3)
0.12 ± 0.24
(34)
Total
(n)
0.02 ±0.01
(8)
0.01 ±0.01
(16)
0.01 ± 0.03
(29)
0.02 ±0.03
(8)
0.11 ± 0.22
(42)
γ Toc/LPO
Male
(n)
0.10 ±0.03
(4)
0.08 ±0.10
(8)
0.09 ± 0.13
(11)
0.13 ±0.31
(5)
0.18 ± 0.20
(15)
Female
(n)
0.11 ±0.13
(4)
0.11 ±0.21
(8)
0.09 ± 0.21
(18)
0.11 ±0.35
(3)
0.22 ± 0.21
(68)
Total
(n)
0.11 ±0.06
(8)
0.09 ±0.10
(16)
0.09 ± 0.19
(29)
0.12 ±0.38
(8)
0.21 ± 0.21
(83)
Toc: Tocopherol; LPO: lipid peroxidase. Note: no signiﬁcant diﬀerences between groups.
Table 7: Correlation coeﬃcient between tocopherol and plasma lipid peroxide.
Plasma tocopherol RBC tocopherol
T-Toc α-Toc β-Toc γ-Toc T-Toc α-Toc β-Toc γ-Toc
Centenarians (n = 139) 0.01 0.11 −0.03 −0.04 0.01 0.02 0.04 −0.06
Septuagenarians (n = 61) 0.34∗∗ 0.33∗∗ −0.02 0.21 −0.32∗ −0.29∗ −0.16 −0.11
∗P<. 05, ∗∗P<. 01.
We did not ﬁnd any signiﬁcant diﬀerences between age
groups for tocopherol: cholesterol and tocopherol: LPO
ratios in centenarians versus younger controls.
Interestingly, a weakly negative correlation was found
between intracellular tocopherol (T-tocopherol and α-
tocopherol) and LPO in septuagenarians. Since mitochon-
dria produce most of the oxidative stress in cells, higher
intracellular levels of tocopherol should result in lower
LPO levels and theoretically, less damage. However, this
ﬁnding was only signiﬁcant in septuagenarians and not in
centenarians, and if this truly represents a protective factor
for survival it is unclear why centenarians would not also
exhibit this ﬁnding. More study of this issue is warranted.
Overall, the literature on oxidative stress as a longevity
factor in humans is sparse. Some data from studies of Italian
centenarians are in agreement with our LPO ﬁndings in
Okinawan centenarians. For example, a study of 15 cente-
narians (3 males; 12 females) recruited from central Italy
compared with equal numbers of controls (young, middle
aged and elderly) showed that blood LPO levels, evaluated
as MDA content, were lower in centenarians than in elderly
control subjects (60–79 years of age) [31]. A larger study by
thesameresearchgroupalsoshowedthatLPOincreasedwith
age until centenarian years where a signiﬁcant decrement
occurred [32]. Centenarian LPO levels were lower than
elderly controls (60–79years) in that study as well buthigher
than young controls (aged 21–40 years). This suggests that
centenarians might have mechanisms to keepoxidative stress
at levels equivalent to persons who are decades younger,
and this could help explain their exceptional longevity.
Susceptibility to peroxidation of the erythrocyte membranes
(when challenged) was also lower in centenarians than in
older controls [32]. Vitamin E was not measured in these
studies but another potential mechanism was identiﬁed.
Centenarians were found to have increased levels of omega-
3 polyunsaturated fatty acids (PUFAs) and reduced content
of omega-6 PUFAs relative to younger controls. Long-chain
omega-3 PUFAs decrease the production of inﬂammatory
eicosanoids, cytokines, and reactive oxygen species by act-
ing directly to inhibit arachidonic acid metabolism and
acting indirectly to modify inﬂammatory gene expression
[33].8 Current Gerontology and Geriatrics Research
While there were tentative links established in the cur-
rent study between oxidative stress and vitamin E in the
Okinawans, we were not able to strongly link vitamin E-
derived tocopherols to reduced oxidative stress across all
measures. LPO was higher in those aged in their 20s, 30s,
and 70s and dropped oﬀ in the 80s and 100s. Most measures
of vitamin E in this study also increased with age until the
70s and then dropped oﬀ. Similar trends have been seen in
studiesofyounger,middle-aged,andolderpersons, although
few studies included exceptionally old persons [8, 34–36].
The literature is mixed with regard to gender diﬀerences,
w i t hr e p o r t so fh i g h e rp l a s m aα-tocopherol in males [37]o r
females [38]. The current study found that females tended to
have signiﬁcantly higher tocopherol (total and α)l e v e l st h a n
males.
The lack of robust support in the current study and
the literature in general for a powerful eﬀect of vitamin E
against LPO does not mean that vitamin E is unimportant to
healthy aging. It is possible that measuring oxidative stress
through TBA may not be the optimal method to assess
vitamin E’s antioxidant eﬀects. Nevertheless, a clinical trial
of vitamin E supplementation of up to 2,000iu/day for 8
weeks was also not supportive of in vivo antioxidative eﬀects.
This study showed no change on three diﬀerent indices of
lipid peroxide (urinary 4-hydroxynonenal and 2 diﬀerent
isoprostanes) [39].
Interestingly, studies that focused on other measures of
systemic defenses against oxidative stress have shown that
centenarians exhibited higher red blood cell glutathione
reductase and catalase activities, which could result in lower
oxidative stress [40]. Studies of Danish centenarians also
found that glutathione reductase activity was higher in
c e n t e n a r i a ne r y t h r o c y t e st h a ni ny o u n g e rc o n t r o l s .T h i sw a s
also linked to healthy aging where centenarians with the
highest cognitive and physical function tended to have the
greatest enzyme activity [41]. These might be fertile areas to
search for relations with vitamin E.
Genes that inﬂuence oxidative stress might also be fertile
areas for investigation, although genetic alterations of model
organisms, including yeast, rodents, worms, and drosophila,
have yielded conﬂicting data. In the fruit ﬂy (Drosophila
melanogaster), overexpression of antioxidative enzymes
through knockout models or other means can dramatically
increase lifespan. Conversely, the absence of CuZn superox-
ide dismutase, a major antioxidant, increases sensitivity to
oxidativedamageandreduceslifespanbyapproximately80%
but genetic rescue of half the enzyme restores lifespan [42,
43]. However, such dramatic eﬀects are not seen in rodent
models where mice with genetic alterations in antioxidant
defenses typically show little alteration in lifespan, but do
show alterations in healthspan [44]. For example, ApoE
null mice have lower serum apolipoprotein E and develop
signiﬁcant early atherosclerosis [45] but overexpression of
catalase, an important antioxidative defense, appears to
confer protection against early atherosclerosis [46].
Interestingly, the two human genes that appear to have
the strongest links to healthy aging and longevity, ApoE and
FOXO3A [47–49] are both linked to oxidative stress. APOE
genotypeinﬂuences oxidativestress and inﬂammation in cell
lines, rodents, and humans [50], and FOXO3A protects cells
from oxidative stress [51]
It is also possible that vitamin-E derived tocopherols
may act through mechanisms that are not clearly linked
to oxidative stress, such as second messenger molecular
signaling [52] and/or other cardioprotective mechanisms
[53], or membrane ﬂuidity [54]. In addition, high vitamin
E consumption may merely reﬂect an overall dietary pattern
that results in healthier aging. For example, work on
Italian centenarians shows that they possess relatively high
plasma vitamin E [55]. Moreover, the traditional healthy
Okinawan diet, which is associated with a high prevalence
of centenarians, has 16.6mg a day of vitamin E, which is a
remarkable 190% of the Japan RDA. This is markedly higher
than the Japanese traditional diet with 6.3mg a day and
72% of the RDA for Japan (RDAJ = males: 10mg/d; females:
8mg/d) [15]. A study of Polish centenarians also showed
that centenarians had high vitamin E levels compared with
healthy, young female adults [40]. However, there has been
no causative link to longevity.
Along the same line of thinking, many epidemiologic
studies show a protective association for vitamin E with
age-related chronic diseases but support from interventional
clinical trials has been lacking [56]. For example, in a
longitudinal study of healthy oldest-old (ages 80-plus), low
plasma concentration of vitamin E and high concentration
of lipid peroxide at baseline predicted risk of cardiovascular
events over a 4-year follow-up [12]. While adjustment for
vitamin C, β-carotene, and serum lipids did not aﬀect
the relation, the possibility still exists that other factors
correlated with vitamin E could have been responsible
for the association. In fact, a cross-sectional epidemiologic
study of over 700 men and women, aged 25–74, showed
that plasma LPO was positively correlated with a great
many cardiovascular risk factors, including triglycerides,
cholesterol subtypes, BMI, ﬁbrinogen, and WBC count,
and was negatively correlated with vitamin C [11]. It is
diﬃcult to control for all such associations in epidemiologic
work, and the possibility that vitamin E is simply correlated
with another more active molecule(s) cannot be completely
ruled out. Indeed, when clinical trials have been conducted
with vitamin E on incidence and progression of age-related
chronic diseases the bulk of the evidence is not supportive of
an important protective eﬀect [56].
It is likely that several mechanisms account for low LPO
at exceptional ages. Exceptional longevity has been linked
to lower caloric intake, more eﬃcient metabolism, increased
insulin sensitivity, among other factors that might lead to
lower oxidative stress [1, 14]. We have also found genetic
factors that may be important, such as variants in HLA
genes that may lead to less inﬂammation [57] and genetic
variants in the FOXO3A gene with potentially pleiotropic
mechanisms for reducing oxidative stress [48].
Finally, if there is truly less ongoing oxidative damage
in centenarians then the etiology is probably complex
and involves interplay of genetic and environmental fac-
tors that operate over a lifetime. A combination of scientiﬁc
approaches will be needed to tease out the important mech-
anisms.Current Gerontology and Geriatrics Research 9
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